Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G

Introduction: Immunotherapy is being used for the past five years either as first line or second line treatment with great results. Chemotherapy and radiotherapy have been also used as combination to immunotherapy to further enhance this type of treatment. Intratumoral treatment has been previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Zhou, Jun, Wang, Qin, Wang, Xiangqi, Xia, Ying, Ding, Yinfeng, Bai, Chong, Kosmidis, Christoforos, Sapalidis, Konstantinos, Sardeli, Chrysanthi, Tsakiridis, Kosmas, Zaric, Bojan, Kovacevic, Tomi, Stojsic, Vladimir, Sarcev, Tatjana, Bursac, Daliborka, Kukic, Biljana, Baka, Sofia, Athanasiou, Evagelia, Hatzibougias, Dimitrios, Michalopoulou-Manoloutsiou, Electra, Petanidis, Savvas, Drougas, Dimitris, Drevelegas, Konstantinos, Paliouras, Dimitris, Barbetakis, Nikolaos, Vagionas, Anastasios, Freitag, Lutz, Lallas, Aimilios, Boukovinas, Ioannis, Petridis, Dimitris, Ioannidis, Aris, Matthaios, Dimitris, Romanidis, Konstantinos, Karapantzou, Chrisanthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040712/
https://www.ncbi.nlm.nih.gov/pubmed/33854617
http://dx.doi.org/10.7150/jca.55322

Ejemplares similares

Ejemplares similares